Mylan execs won’t testify at Senate hearing

Published



Executives of EpiPen maker Mylan will not testify before Congress about its settlement with the Justice Department over allegations it bilked Medicaid, angering a top GOP senator.

Mylan joined the Justice Department in declining to testify at a Nov. 30 Senate hearing on a settlement over Medicaid rebates for the allergy drug whose price was raised by Mylan to about $600 for a two-pack.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.